FAST vs SCNI · P/E 43, rev $4.59B vs P/E 0.2, rev $1.3M
Fastenal Company (FAST) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the FAST and SCNI stock pages for the full models.
Not investment advice.